Perioperative Anti-Fibrotic Treatment Prevents Acute Exacerbation of Idiopathic Pulmonary Fibrosis After Lung Cancer Surgery

Perioperative Anti-Fibrotic Treatment Prevents Acute Exacerbation of Idiopathic Pulmonary Fibrosis After Lung Cancer Surgery

Background: The surgical treatment of concomitant lung cancer in patients with idiopathic pulmonary fibrosis is challenging due to the risk of life-threatening complications such as acute exacerbation development in the perioperative period. Few studies have investigated the role of anti-fibrotic dr...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefano Bongiolatti, Alberto Salvicchi, Elisabetta Rosi, Elena Bargagli, Giovanni Mugnaini, Alessandro Gonfiotti, Federico Lavorini, Paolo Spagnolo, Andrea Dell’Amore, Federico Rea, Luca Voltolini
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Life
Subjects:
anti-fibrotic treatment
pirfenidone
nintedanib
lung surgery
acute exacerbation
Online Access:https://www.mdpi.com/2075-1729/14/11/1506
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2075-1729/14/11/1506

Similar Items